Registration

THE KPM GROUP DC LLC for SANGAMO THERAPEUTICS, INC

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization

LobbyistCovered position, as disclosed
KATHERINE LANDES New —
PATROSKI LAWSON New —
BENJAMIN MASON New Communications Director, Rep. David Young January 2017 - June 2017

Bills named: H.R. 1730 (116th), S. 670 (116th)

Pharmacy PHA

Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization

LobbyistCovered position, as disclosed
KATHERINE LANDES New —
PATROSKI LAWSON New —
BENJAMIN MASON New Communications Director, Rep. David Young January 2017 - June 2017

Bills named: H.R. 1730 (116th), S. 670 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.